VIIITH NERVE LESION

VIIITH NERVE LESION was reported 46 times

VIIITH NERVE LESION is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Antimycobacterial [EPC] 3 0.0001
1 Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] 1 0.0001
2 Rifamycin Antibacterial [EPC] 2 0.0001
3 Nucleoside Analog Antiviral [EPC] 4 0.0000
4 Iron Chelator [EPC] 1 0.0000
5 Oxazolidinone Antibacterial [EPC] 1 0.0000
6 Proteasome Inhibitor [EPC] 3 0.0000
7 Pyridone [EPC] 1 0.0000
8 Epidermal Growth Factor Receptor Antagonist [EPC] 1 0.0000
9 Macrolide Antimicrobial [EPC] 1 0.0000
10 Alkylating Drug [EPC] 4 0.0000
11 Leukocyte Growth Factor [EPC] 2 0.0000
12 Interferon beta [EPC] 2 0.0000
13 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 1 0.0000
14 Programmed Death Receptor-1 Blocking Antibody [EPC] 1 0.0000
15 Aminosalicylate [EPC] 1 0.0000
16 Mood Stabilizer [EPC] 2 0.0000
17 Parathyroid Hormone Analog [EPC] 1 0.0000
18 Aromatase Inhibitor [EPC] 1 0.0000
19 Osmotic Laxative [EPC] 2 0.0000
20 Calcium [EPC] 1 0.0000
21 Insulin Analog [EPC] 3 0.0000
22 beta-Adrenergic Blocker [EPC] 2 0.0000
23 Tumor Necrosis Factor Blocker [EPC] 6 0.0000
24 Vascular Endothelial Growth Factor Inhibitor [EPC] 1 0.0000
25 Estrogen [EPC] 1 0.0000
26 Proton Pump Inhibitor [EPC] 3 0.0000
27 Expectorant [EPC] 1 0.0000
28 Thiazide Diuretic [EPC] 1 0.0000
29 Vitamin C [EPC] 2 0.0000
30 Corticosteroid [EPC] 6 0.0000
31 Opioid Agonist [EPC] 1 0.0000
32 Nucleoside Metabolic Inhibitor [EPC] 1 0.0000
33 CD20-directed Cytolytic Antibody [EPC] 1 0.0000
34 Angiotensin 2 Receptor Blocker [EPC] 1 0.0000
35 Folate Analog Metabolic Inhibitor [EPC] 1 0.0000
36 Thalidomide Analog [EPC] 1 0.0000
37 Benzodiazepine [EPC] 1 0.0000
38 Nonsteroidal Anti-inflammatory Drug [EPC] 1 0.0000